UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Choosing the right rewards requires understanding several factors. This guide highlights what you should consider for optimal benefits.
17,409 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Retirees are dialing in on steady monthly income. Here are five dependable dividend pay stocks that aim to deliver re...
As Cricut reports its 2025 earnings, investors weigh growth engines, profitability, and strategic bets. This guide br...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
A new state-grade iOS exploit kit is slipping past Apple defenses to drain crypto wallets on iPhone. Researchers warn...
As the world ages, demand for life-saving medical devices grows. This article breaks down three pragmatic reasons why...
A single, high-stakes scenario could ripple through the U.S. power grid, telecom networks, and financial systems. Thi...
When a niche tech stock makes a big leap, investors want to know why. This deep dive explains the factors behind IPG ...
Desalination facilities in the region are at the center of rising tensions, elevating the mideast’s water supply risk...
Markets are calm on the surface as oil climbs and regional tensions flare. Yet history suggests a fragile calm, with ...
Freightcar America (Rail) earnings can signal the health of a cyclical market. This guide breaks down the numbers, si...
Oil and fuel costs are rising as tensions with Iran intensify. This report explains how energy markets are influencin...